
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Novanta Inc (NOVT)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/13/2025: NOVT (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $147.32
1 Year Target Price $147.32
1 | Strong Buy |
2 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.05% | Avg. Invested days 42 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.68B USD | Price to earnings Ratio 66.67 | 1Y Target Price 147.32 |
Price to earnings Ratio 66.67 | 1Y Target Price 147.32 | ||
Volume (30-day avg) 4 | Beta 1.46 | 52 Weeks Range 98.76 - 187.12 | Updated Date 06/30/2025 |
52 Weeks Range 98.76 - 187.12 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.95 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 7.42% | Operating Margin (TTM) 12.84% |
Management Effectiveness
Return on Assets (TTM) 5.75% | Return on Equity (TTM) 9.73% |
Valuation
Trailing PE 66.67 | Forward PE - | Enterprise Value 5013773284 | Price to Sales(TTM) 4.91 |
Enterprise Value 5013773284 | Price to Sales(TTM) 4.91 | ||
Enterprise Value to Revenue 5.27 | Enterprise Value to EBITDA 27.46 | Shares Outstanding 35970800 | Shares Floating 35633066 |
Shares Outstanding 35970800 | Shares Floating 35633066 | ||
Percent Insiders 0.86 | Percent Institutions 103.17 |
Analyst Ratings
Rating 2 | Target Price 147.32 | Buy 2 | Strong Buy 1 |
Buy 2 | Strong Buy 1 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Novanta Inc
Company Overview
History and Background
Novanta Inc. was founded in 1997 as GSI Lumonics, later rebranded as Novanta in 2013. It has grown through strategic acquisitions and organic growth, focusing on precision photonic and motion control components and subsystems.
Core Business Areas
- Precision Medicine and Manufacturing: Designs, manufactures, and sells optical, photonic, and electronic components and subsystems used in medical and advanced industrial applications. Includes laser beam steering, precision microfluidics and laser micro machining.
- Vision: Develops and delivers imaging solutions, primarily for machine vision and inspection applications. These offerings include embedded vision, cameras, and illumination solutions.
- Robotics: Provides automation solutions for robotic surgery, lab automation and robotic assembly. Products include precision motors, encoders, and integrated motion solutions.
Leadership and Structure
Novanta Inc. is led by Matthijs Glastra as CEO. The company operates with a functional organizational structure across its various business segments. The Board of Directors provides oversight and strategic direction.
Top Products and Market Share
Key Offerings
- Laser Beam Steering Components: Components used in laser marking, cutting, and welding systems. Market share data is difficult to ascertain precisely, but Novanta is a significant player in this sector, competing with companies like Scanlab and Coherent Corp. Revenue is integrated across precision medicine and manufacturing segment. The competition includes companies like Scanlab GmbH and Coherent Corp (COHR).
- Precision Motion Control Systems: Products include servo drives, motors, and encoders used in various industrial automation and medical applications. Competes with providers such as Moog (MOG.A) and Kollmorgen. Revenue is integrated across precision medicine and manufacturing and robotics segments.
- Medical Grade Power Solutions: Designs and manufactures standard and custom power conversion solutions for medical applications. Competitors include companies like Advanced Energy (AEIS) and SL Power Electronics. Market data is difficult to ascertain precisely as revenue is not broken out into segments.
Market Dynamics
Industry Overview
The markets Novanta serves are experiencing growth driven by increasing demand for automation, precision manufacturing, and advanced medical technologies. Aging populations and the need for minimally invasive procedures are also fueling demand.
Positioning
Novanta is positioned as a key supplier of enabling technologies for OEMs in its target markets. Its competitive advantages include its broad product portfolio, technical expertise, and global presence.
Total Addressable Market (TAM)
The estimated TAM for Novanta's served markets is in the billions of dollars. They are positioned well to capture a significant portion of this TAM with their diverse product offerings and strong market presence. Although the exact figures are not readily available, the market is vast, with increasing growth prospects.
Upturn SWOT Analysis
Strengths
- Diversified product portfolio
- Strong market position in niche applications
- Technical expertise and innovation
- Global presence
- Acquisition expertise
Weaknesses
- Dependence on specific industries and customers
- Exposure to economic cycles
- Integration risks associated with acquisitions
- High valuation relative to peers
Opportunities
- Expanding into new geographic markets
- Developing new products and applications
- Acquiring complementary businesses
- Leveraging technology to improve efficiency
Threats
- Increased competition
- Technological obsolescence
- Economic downturn
- Supply chain disruptions
- Geopolitical risks
Competitors and Market Share
Key Competitors
- COHR
- MOG.A
- AEIS
Competitive Landscape
Novanta competes based on its technological expertise, breadth of product offerings, and strong customer relationships. Its smaller size can be an advantage in terms of agility and focus, but a disadvantage in terms of resources compared to larger competitors.
Major Acquisitions
Laser Optek GmbH
- Year: 2021
- Acquisition Price (USD millions): 178
- Strategic Rationale: Expands Novanta's presence in the medical aesthetics market and adds complementary laser technology.
Growth Trajectory and Initiatives
Historical Growth: Novanta has demonstrated strong historical growth through a combination of organic initiatives and strategic acquisitions.
Future Projections: Analysts project continued growth for Novanta, driven by increasing demand for its products and services in its target markets. Revenue growth in the high single digits to low teens is forecasted.
Recent Initiatives: Recent initiatives include acquisitions to expand product offerings and market reach, as well as investments in research and development to drive innovation.
Summary
Novanta is a strong company with a diversified product portfolio and solid market position in its niche segments. Its strategic acquisitions have fueled growth, but the company must manage integration risks and maintain its technological edge. Positive cash flow and a healthy balance sheet support its growth strategy, although economic cycles and increased competition pose ongoing challenges. Overall, Novanta appears to be well positioned for future growth, but execution is critical.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (10-K, 10-Q), Investor presentations, Industry reports, Analyst estimates
- Yahoo Finance
- Google Finance
- Company website
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market share data is based on estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Novanta Inc
Exchange NASDAQ | Headquaters Bedford, MA, United States | ||
IPO Launch date 2016-01-04 | CEO & Chairman of the Board Mr. Matthijs Glastra | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 3000 | Website https://www.novanta.com |
Full time employees 3000 | Website https://www.novanta.com |
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.